miltefosine has been researched along with 3-methylbutanoic acid [(2R,3S,6S,7R)-3-[[(3-formamido-2-hydroxyphenyl)-oxomethyl]amino]-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl] ester in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chandrakar, P; Gunaganti, N; Kar, S; Kumar, A; Mitra, K; Narender, T; Parmar, N; Rashid, M; Singh, SK; Wahajuddin, M | 1 |
1 other study(ies) available for miltefosine and 3-methylbutanoic acid [(2R,3S,6S,7R)-3-[[(3-formamido-2-hydroxyphenyl)-oxomethyl]amino]-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl] ester
| Article | Year |
|---|---|
β-Amino acid derivatives as mitochondrial complex III inhibitors of L. donovani: A promising chemotype targeting visceral leishmaniasis.
Topics: Amino Acids; Animals; Antiprotozoal Agents; Cell Survival; Chlorocebus aethiops; Cricetinae; Dose-Response Relationship, Drug; Electron Transport Complex III; Leishmania donovani; Leishmaniasis, Visceral; Mice; Mice, Inbred BALB C; Mitochondria; Molecular Structure; Parasitic Sensitivity Tests; Structure-Activity Relationship; Vero Cells | 2019 |